Title : Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the (68)Ga- and (177)Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)(2) - Lappchen_2024_Molecules_29_ |
Author(s) : Lappchen T , Bilinska A , Pilatis E , Menendez E , Imlimthan S , Moon ES , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E |
Ref : Molecules , 29 : , 2024 |
Abstract : |
PubMedSearch : Lappchen_2024_Molecules_29_ |
PubMedID: 38999044 |
Title : Translational assessment of a DATA-functionalized FAP inhibitor with facile (68)Ga-labeling at room temperature - Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202 |
Author(s) : Escudero-Castellanos A , Kurth J , Imlimthan S , Menendez E , Pilatis E , Moon ES , Lappchen T , Rathke H , Schwarzenbock SM , Krause BJ , Rosch F , Rominger A , Gourni E |
Ref : Eur J Nucl Med Mol Imaging , 50 :3202 , 2023 |
Abstract : |
PubMedSearch : Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202 |
PubMedID: 37284857 |
Title : Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to (18)F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines - Poulie_2023_Eur.J.Med.Chem_262_115862 |
Author(s) : Poulie CBM , Shalgunov V , Elvas F , Van Rymenant Y , Moon ES , Battisti UM , De Loose J , De Meester I , Rosch F , Van der Veken P , Herth MM |
Ref : Eur Journal of Medicinal Chemistry , 262 :115862 , 2023 |
Abstract : |
PubMedSearch : Poulie_2023_Eur.J.Med.Chem_262_115862 |
PubMedID: 37883899 |
Title : In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA(5).SA.FAPi and DOTA.SA.FAPi - Moon_2021_Molecules_26_3482 |
Author(s) : Moon ES , Van Rymenant Y , Battan S , De Loose J , Bracke A , Van der Veken P , De Meester I , Rosch F |
Ref : Molecules , 26 :3482 , 2021 |
Abstract : |
PubMedSearch : Moon_2021_Molecules_26_3482 |
PubMedID: 34201111 |
Gene_locus related to this paper: human-FAP |
Title : New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress - Imlimthan_2021_Pharmaceuticals.(Basel)_14_ |
Author(s) : Imlimthan S , Moon ES , Rathke H , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E |
Ref : Pharmaceuticals (Basel) , 14 : , 2021 |
Abstract : |
PubMedSearch : Imlimthan_2021_Pharmaceuticals.(Basel)_14_ |
PubMedID: 34681246 |
Gene_locus related to this paper: human-FAP |
Title : Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA(5m) chelators - Moon_2020_EJNMMI.Radiopharm.Chem_5_19 |
Author(s) : Moon ES , Elvas F , Vliegen G , De Lombaerde S , Vangestel C , De Bruycker S , Bracke A , Eppard E , Greifenstein L , Klasen B , Kramer V , Staelens S , De Meester I , Van der Veken P , Rosch F |
Ref : EJNMMI Radiopharm Chem , 5 :19 , 2020 |
Abstract : |
PubMedSearch : Moon_2020_EJNMMI.Radiopharm.Chem_5_19 |
PubMedID: 32728930 |
Title : Demonstration of pulmonary beta2-adrenergic receptor binding in vivo with [18F]fluoroethyl-fenoterol in a guinea pig model - Helisch_2005_Eur.J.Nucl.Med.Mol.Imaging_32_1324 |
Author(s) : Helisch A , Schirrmacher E , Thews O , Schirrmacher R , Buchholz HG , Dillenburg W , Hohnemann S , Tillmanns J , Wessler I , Buhl R , Rosch F , Bartenstein P |
Ref : Eur J Nucl Med Mol Imaging , 32 :1324 , 2005 |
Abstract : |
PubMedSearch : Helisch_2005_Eur.J.Nucl.Med.Mol.Imaging_32_1324 |
PubMedID: 16133376 |
Title : Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-ben zene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lung - Schirrmacher_2003_Bioorg.Med.Chem.Lett_13_2687 |
Author(s) : Schirrmacher E , Schirrmacher R , Thews O , Dillenburg W , Helisch A , Wessler I , Buhl R , Hohnemann S , Buchholz HG , Bartenstein P , Machulla HJ , Rosch F |
Ref : Bioorganic & Medicinal Chemistry Lett , 13 :2687 , 2003 |
Abstract : |
PubMedSearch : Schirrmacher_2003_Bioorg.Med.Chem.Lett_13_2687 |
PubMedID: 12873495 |